Overview

To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain

Status:
Completed

Trial end date:
2016-09-01

Target enrollment:

Participant gender:

Summary

This study is aimed to demonstrate equivalence between combinations of lower strength OXN PR tablets (OXN PR LST) and single higher strength OXN PR tablets (OXN PR HST) taken at the same overall daily dose.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Mundipharma Research GmbH & Co KG

Treatments:

Analgesics
Naloxone
Oxycodone